scPharmaceuticals Inc (SCPH)
4.66
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
4.65
-0.01
(-0.21%)
Pre-Market: 20:00
scPharmaceuticals Cash from Operations (TTM): -59.24M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -59.24M |
| September 30, 2023 | -55.92M |
| June 30, 2023 | -50.67M |
| March 31, 2023 | -43.70M |
| December 31, 2022 | -34.58M |
| September 30, 2022 | -29.84M |
| June 30, 2022 | -26.81M |
| March 31, 2022 | -25.90M |
| December 31, 2021 | -27.15M |
| September 30, 2021 | -29.23M |
| June 30, 2021 | -28.87M |
| March 31, 2021 | -28.56M |
| December 31, 2020 | -27.69M |
| Date | Value |
|---|---|
| September 30, 2020 | -33.35M |
| June 30, 2020 | -34.12M |
| March 31, 2020 | -32.07M |
| December 31, 2019 | -30.44M |
| September 30, 2019 | -21.41M |
| June 30, 2019 | -21.30M |
| March 31, 2019 | -25.86M |
| December 31, 2018 | -28.81M |
| September 30, 2018 | -28.95M |
| June 30, 2018 | -29.37M |
| March 31, 2018 | -27.01M |
| December 31, 2017 | -22.68M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-59.24M
Minimum
Dec 2023
-21.30M
Maximum
Jun 2019
-33.73M
Average
-29.84M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| Anika Therapeutics Inc | -1.788M |
| Spero Therapeutics Inc | -33.00M |
| electroCore Inc | -14.67M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |